Smith Group Asset Management LLC purchased a new position in shares of UiPath Inc. (NYSE:PATH – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 9,020 shares of the healthcare company’s stock, valued at approximately $204,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in PATH. Mark Sheptoff Financial Planning LLC bought a new stake in shares of UiPath during the 4th quarter worth about $25,000. HighMark Wealth Management LLC bought a new stake in shares of UiPath during the 4th quarter worth about $27,000. Cypress Capital Management LLC WY bought a new stake in shares of UiPath in the 4th quarter worth approximately $29,000. GAMMA Investing LLC bought a new stake in shares of UiPath in the 4th quarter worth approximately $36,000. Finally, FNY Investment Advisers LLC bought a new stake in shares of UiPath in the 4th quarter worth approximately $40,000. 62.50% of the stock is currently owned by institutional investors.
UiPath Price Performance
PATH traded up $0.28 on Friday, reaching $13.24. 7,620,131 shares of the company traded hands, compared to its average volume of 10,134,202. The stock’s 50 day moving average price is $15.54 and its 200-day moving average price is $20.38. UiPath Inc. has a 52-week low of $11.07 and a 52-week high of $27.87. The company has a market cap of $7.58 billion, a price-to-earnings ratio of -82.81 and a beta of 0.86.
Analysts Set New Price Targets
A number of analysts recently commented on the stock. Mizuho dropped their target price on shares of UiPath from $25.00 to $14.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. DA Davidson dropped their target price on shares of UiPath from $24.00 to $13.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. Macquarie downgraded shares of UiPath from an “outperform” rating to a “neutral” rating and dropped their target price for the stock from $29.00 to $12.00 in a report on Monday, June 3rd. Evercore ISI dropped their target price on shares of UiPath from $27.00 to $13.00 and set an “in-line” rating on the stock in a report on Thursday, May 30th. Finally, Barclays dropped their target price on shares of UiPath from $25.00 to $16.00 and set an “equal weight” rating on the stock in a report on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, UiPath has a consensus rating of “Hold” and an average price target of $18.06.
Get Our Latest Report on UiPath
Insiders Place Their Bets
In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the sale, the chief financial officer now directly owns 946,848 shares of the company’s stock, valued at $18,738,121.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 22.37% of the company’s stock.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- Investing in large cap stocks: Diving into big caps
- MarketBeat Week in Review – 7/1 – 7/5
- What Are Trending Stocks? Trending Stocks Explained
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- How to Calculate Options Profits
- Qualcomm Stock Continues to Rise in the Face of Negative News
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.